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Abstract 
Human implantation involves a major invasion of the uterus wall and a complete remodelling 
of the uterine arteries by the extravillous cytotrophoblasts (EVCT). Abnormality of these 
early steps of placental development leads to poor placentation, fetal growth defects and is 
very often associated with preeclampsia, a major and frequent complication of human 
pregnancy. To study the mechanisms that control trophoblast invasion during early placental 
development and to provide new insight in the understanding of preeclampsia, we have 
developed in vitro models of human invasive trophoblasts. We showed that activation of the 
ligand-activated nuclear receptor PPAR with synthetic (rosiglitazone) or natural 
(15deoxyPGJ2) agonists inhibits the trophoblastic invasion process. Analysis of PPAR-target 
genes revealed that placental growth hormone and the protease PAPP-A might be involved in 
the PPAR-mediated effect in an autocrine manner. We next investigated for PPAR ligands 
at the maternofetal interface and showed that oxidized-LDLs are present in EVCT in situ and 
decrease trophoblast invasion in vitro. Analysis of oxidized-LDLs revealed that they contain 
potent PPAR agonists such as eicosanoids but also high levels of oxysterols, which are 
specific ligands for the liver X receptor. The isoform ß of LXR was found in EVCT in situ, 
and activation of LXRß with synthetic or natural ligands inhibits trophoblast invasion in vitro. 
Together, our data underscore a major role for PPAR and LXRß in the control of human 
trophoblast invasion and suggest that excess of ligands such as oxidized-LDLs at the 
implantation site might contribute to the development of preeclampsia. 
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Development of human placenta 
Implantation of the human conceptus involves the invasion of the uterine epithelium 
and the underlying stroma by extra embryonic trophoblastic cells, which undergo a complex 
process of proliferation, migration and differentiation. One particularity of human 
placentation is the very high degree of trophoblast invasion during the first trimester (Aplin, 
1991) unparalleled in other mammals. The trophoblasts named extravillous cytotrophoblasts 
(EVCT) invade the uterine wall and the associated arterioles where they replace the 
endothelial lining and most of the musculoelastic tissue of the vessel wall. This arteriole 
remodelling leads to low resistance vessels that provide adequate supply of maternal blood for 
fetal growth (Loke and King, 1995). The human trophoblastic invasion, unlike tumour 
invasion, is precisely regulated. It is temporally restricted to early pregnancy and it is spatially 
confined to the endometrium, the first third of the myometrium and the associated uterine 
arterioles (Fisher and Damsky, 1993; Redman, 1997). Trophoblast migration and invasive 
capacity have been shown to be modulated by numerous factors including oxygen 
concentration (Zhou et al, 1998), transforming growth factor (TGF-), IGF-II and IGFBP-1 
(Irving and Lala, 1995; Hamilton et al, 1998), epidermal growth factor (Bass et al, 1994) and 
hepatocyte growth factor (Cartwright et al, 1999).  
Defective invasion of the uterine spiral arteries is directly involved in preeclampsia, a 
major and frequent complication of human pregnancy with serious foetal and maternal 
consequences (for review see Redman et al, 1993). Due to the specificity of the human 
placenta, no easily accessible animal models are available to study trophoblast invasion and 
the pathophysiology of preeclampsia. Hence, we have developed two in vitro models to 
investigate the regulation of human trophoblast differentiation and invasion (Tarrade et al, 
2001a and 2001b, Pavan et al, 2003, Handschuh et al, 2006a and 2006b). 
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In vitro model of human invasive extravillous cytotrophoblasts (Cf. Figure 1) 
 The first model consists of primary cultures of trophoblastic cells isolated by gentle 
enzymatic digestion from first trimester chorionic villi and purified as previously described 
(Tarrade et al, 2001a and 2001b, Handschuh et al, 2006a). Cultured on an extra cellular 
matrix such as Matrigel, these cells are non proliferative and express specific markers of 
invasive EVCT such as cytokeratin 7 (CK7), human leukocyte antigen-G (HLA-G), human 
placental lactogen (hPL), the protooncogene c-erbB2, CD9 and the alpha5 subunit of the 
alpha5-beta1 fibronectin receptor (Tarrade et al, 2001a and 2001b; Pavan et al, 2003). The 
second model of human invasive trophoblasts was obtained from a primary culture of EVCT 
transformed with the simian virus 40 large T antigen. This trophoblastic cell line (HIPEC65) 
is proliferative and highly invasive when cultured on Matrigel and have been fully 
characterized (Pavan et al, 2003). HIPEC 65 cells express the CK7, HLA- G and CD9, the 
three essential antigens considered as EVCT specific markers as established in two workshop 
reports (King et al, 2000; Shiverick et al, 2001). In addition, markers of invasive trophoblasts 
including c-erbB2, TGFß2 and alpha5 subunit are also expressed by HIPEC65. 
 
Expression and role of PPAR/RXR heterodimers in early placental development  
 The peroxisome proliferator-activated receptor- (PPAR) is a member of the nuclear 
receptor superfamily that controls the expression of a large array of genes in a ligand-
dependent manner. DNA binding of PPAR to its response element (composed of a direct 
repeat of the core hexanucleotide motif AGGTCA with one intervening base named DR1) 
requires obligate heterodimerization with another nuclear receptor, the retinoid X receptor 
(RXR) (for review see Desvergne and Whali, 1999). PPAR is bound and activated by natural 
ligands such as eicosanoids, fatty acids and oxidized low-density lipoprotein compounds. 15-
deoxy-delta (12,14) prostaglandin J2 (15d-PGJ2) is considered as a potent natural PPAR 
 5 
agonist (Kliewer et al, 1997; Nagy et al, 1998; Forman et al, 1995). In addition, synthetic 
agonists of PPAR, such as rosiglitazone that belongs to the thiazolidinedione class of drugs, 
have been developed and used in the treatment of type 2 diabetes. PPAR/RXR heterodimers 
can be activated by either selective RXR (9-cis retinoic acid) or PPAR ligands, the 
combination resulting in an additive or synergistic effect.  
 In 1999, genetic studies performed in mice established that two nuclear hormone 
receptors, RXRs, on the one hand, and PPAR, on the other hand, are essential for placental 
development and vasculature. Indeed, RXR-/- /RXR-/- conceptuses fail to develop a normal 
chorioallantoic placenta with a functional labyrinthine zone, resulting in compromised 
maternal-fetal exchanges and therefore in early embryonic death (Wendling et al, 1999). 
Likewise, PPAR-/- conceptuses exhibited similar placental agenesis with defects in 
trophoblast differentiation and vascular processes (Barak et al, 1999; Kubota et al, 1999). 
These studies demonstrated that PPAR/RXR heterodimers are essential for implantation and 
the formation of a functional placenta in mice.  
 In human placenta, PPAR is specifically expressed in the villous cytotrophoblast 
(VCT) and syncytiotrophoblast, as well as in the EVCT along their differentiation pathway, 
including proliferative and intermediate EVCT in the proximal and distal columns of the 
anchoring villi, invasive EVCT located in the deciduas, endovascular and perivascular EVCT, 
and giant cells (for review see Fournier et al, 2006). Therefore, PPAR may be used as a 
marker of human trophoblast. By contrast, a pleiotropic expression of the isoform alpha of 
RXRwas found at the maternofoetal interface RXR being expressed in trophoblast 
from villous and extravillous origin, the mesenchymal core of the villi and the different 
components of the deciduas (Tarrade et al, 2000; Tarrade et al 2001b). Thus, these 
histological studies demonstrated that at the maternofetal interface, PPAR/RXR 
heterodimers are exclusively located in the trophoblasts. 
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 Using the two in vitro models of human invasive trophoblast, we showed that both 
primary cultures of EVCT and HIPEC65 cells express high levels of PPAR and RXR, 
which can be colocalized in the nuclei by immunocytochemistry. Activation of PPAR/RXR 
heterodimers by either natural (15d-PGJ2) or synthetic (rosiglitazone) PPAR ligands 
markedly decreased cell invasion in a concentration-dependent manner as assayed in Boyden 
chambers as illustrated in Figure 2 (Tarrade et al, 2001b; Fournier et al, 2002; Pavan et al, 
2003). Interestingly, whereas in numerous cellular models PPAR activation inhibits both cell 
proliferation and migration (Grommes et al, 2006; Liu et al, 2005), it did not modify cell 
growth in HIPEC65 cells suggesting that inhibition of cellular invasiveness by PPAR 
agonists without alteration of cell growth might be specific to trophoblastic cells (Pavan et al, 
2003). 
 
Mechanisms involved in the inhibition of trophoblast invasion by PPAR 
 Cellular invasion requires different steps such as lost of cell-cell adhesion and 
communication, modification of receptors to the matrix such as integrins, protease activation 
promoting matrix degradation, cytoskeletal activation and secretion of soluble factors 
promoting cell migration. We observed that activation of PPAR by the specific agonist 
rosiglitazone significantly down regulated gene expressions of the human placental growth 
hormone (hPGH) and of the pregnancy-associated plasma protein A (PAPP-A) (Handschuh et 
al, 2006a).  
 Hormones belonging to the GH/prolactin family are expressed at the maternofetal 
interface and are involved in cell motility in various models. We examined the possible 
regulatory role of hPGH in EVCT invasiveness. First, we found in situ by 
immunohistochemistry performed on first trimester human placental sections that EVCT 
expressed both hPGH and human GH receptor (hGHR). Using the Matrigel-coated transwell 
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invasion model, we observed strong hPGH and hGHR expression when EVCT invaded 
Matrigel and moved through the pores of the filter on which they were cultured. Incubation of 
EVCT with exogenous hPGH stimulated trophoblast invasiveness through activation of the 
Janus kinase-2/signal transducer and activator of transcription factor-5 signalling pathway 
(Cf. Figure 3) (Lacroix et al, 2005). These results provide evidence that hPGH participates to 
the control of trophoblast invasiveness and as a PPAR target gene, might be involved in the 
PPAR-mediated inhibition of trophoblast invasion in an autocrine manner.  
 PAPP-A is a metzincin metalloproteinase that increases in maternal serum during 
pregnancy. It cleaves the insulin-like growth factor-dependent binding protein-4 (IGFBP-4) 
and consequently modulates the amount of bioactive IGF-II, a factor known to promote 
trophoblast invasion. The expression of PAPP-A and its regulation by PPAR were studied in 
vitro using primary cultures of invasive extravillous (EVCT) and endocrine villous (VCT) 
cytotrophoblasts isolated from the same first trimester chorionic villi. First, we demonstrated 
that invasive EVCT expressed and secreted 10 times more PAPP-A than the endocrine VCT 
suggesting that PAPP-A might be considered as an early marker of physiological trophoblast 
invasion. Then, we showed that activation of PPAR inhibited PAPP-A gene expression and 
secretion specifically in EVCT, whereas it had no effect in VCT (Cf. Figure 4) (Handschuh et 
al, 2006a). These results strongly suggest that the PPAR-induced decrease in PAPP-A 
observed in invasive EVCT might diminish the amount of bioactive IGF-II, a factor that 
promotes trophoblast invasion. 
 
PPAR ligands at the maternofetal interface  
Lipid metabolism is profoundly altered during human pregnancy and it has been reported that 
LDL, which are involved in the plasma transport of triglycerides, are smaller, denser and 
more susceptible to oxidation during pregnancy (Winkler et al, 2000; Anber et al, 1996).
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 Oxidized metabolites of linoleic acid such as 9- and 13-hydroxy-octadedienoic acid 
(HODE) are found in oxidized low-density lipoproteins and were identified as PPAR 
specific ligands (Nagy et al, 1998). In addition, oxidized lipids including 9S-HODE, 13S-
HODE, 15S-hydroxy-5Z,11Z,13E-eicosatetraenoic acid (15S-HETE) were shown to activate 
PPAR in primary human villous trophoblasts (Schild et al, 2002). We therefore hypothesized 
that oxidative modification of LDL particles in the blood and/or at the placental bed site 
might be involved in modulating trophoblast invasion during the early stages of placental 
development. We assessed the distribution of oxidized LDLs (oxLDL) in sections of first 
trimester placenta and studied the effect of oxLDL on trophoblast invasion in vitro. We 
showed by immunohistochemistry that oxLDL were present in cytotrophoblasts of villous and 
extravillous origin and demonstrated using our in vitro invasion assay that oxLDL, but not 
native LDL, inhibited trophoblast invasion in a concentration-dependent manner as illustrated 
in Figure 5A) (Pavan et al, 2004a). Analysis of oxLDL content revealed that only oxLDL 
containing a high proportion of oxysterols and phosphatidylcholine hydroperoxide 
derivatives, reduced trophoblast invasion. Phosphatidylcholine hydroperoxide derivatives 
provide PPAR ligands such as HETE and HODE, whereas oxysterols such as 7 
ketocholesterol provide ligands to another nuclear receptor, the liver X receptor (LXR) that 
also heterodimerize with RXR. In addition to PPAR and RXR, the isoform beta of LXR 
was found in the nuclei of primary EVCT. Finally, we showed that activation of 
PPAR/RXR or RXR/LXRß heterodimers with specific natural and synthetic PPAR or 
LXR ligands markedly inhibit trophoblast invasion in vitro (Cf. Figure 5B) (Pavan et al, 
2004b). The clinical relevance of these in vitro findings was enforced by the 
coimmunodetection in situ of oxLDLs, the scavenger receptor LOX-1 involved in oxLDL 
uptake, and the two nuclear receptors PPAR and LXRß in invasive EVCT at the 
maternofoetal interface (Cf. Figure 6) (Pavan et al, 2004a). Interestingly, LOX-1 protein 
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levels were shown to be increased in preeclamptic placental tissues and a significant higher 
number of LOX-1 positive syncyciotrophoblast was found in preeclamptic compared to 
normal placentas (Lee et al, 2005). Despite the absence of data concerning LOX-1 expression 
in EVCT (the trophoblasts involved in trophoblastic invasion) from preeclamptic placentas, 
we can speculate that increase number of LOX-1 EVCT might lead to increase oxidized-
LDLs uptake and inhibition of trophoblastic invasion contributing therefore to the 
pathogenesis of preeclampsia. 
 
 In conclusion, our results suggest that human trophoblast invasion might be regulated 
by oxidized LDLs in vivo through activation of the nuclear receptors PPAR and LXRß, and 
provide new insights into the pathophysiology of preeclampsia associated with oxidative 
stress and defective trophoblast invasion. Mechanisms by which oxidized LDLs present at the 
maternofetal interface might inhibit human trophoblast invasion are illustrated in figure 7. 
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Figure legends 
 
Figure 1. In vitro models for studying human trophoblast invasion 
Human extravillous cytotrophoblasts (EVCT) isolated from first trimester anchoring villi are 
immunostained using anti-cytokeratin 7 antibodies and nuclei counter stained with Dapi. The 
cell line HIPEC65 was obtained by transformation of primary EVCT with SV40 T/t antigens. 
For invasion assay, primary EVCT or HIPEC65 were cultured on Matrigel-coated transwell. 
Cells invaded the Matrigel and cross the 8 µm diameter pores of the membrane as illustrated  
by scanning electron microscopy. Pseudopodia and cells crossing the porous membrane were 
quantified and normalized to the number of nuclei after immunostaining with anti-CK7 
antibody and counter stained with Dapi.  
 
Figure 2. Expression and role of PPAR and RXR in primary EVCT and HIPEC65 
cells. 
Upper panel:  Immunolocalization of PPAR and RXR in the nuclei of ECVT after 48 h of 
culture on Matrigel and in HIPEC65 cells. No staining was observed when incubated with 
non-immune antibodies (IgG). 
Lower panel: EVCT were cultured on matrigel-coated transwells for 48 h and invasion was 
quantified as described in Figure 1. Results are expressed as number of pseudopodes per 
number of nuclei relative to control. EVCT were incubated with increasing concentrations of 
rosiglitazone or d15-PGJ2. Results represent the mean ± SD of at least 3 different cultures. * 
p<0.05 treated vs control. 
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Figure 3. Human PGH increased trophoblast invasion through activation of the 
Jak/STAT pathway.  
Left panel: EVCT were grown on Matrigel-coated transwell for 72 h in the presence or 
absence of increasing concentrations of hPGH. 
Right panel : EVCT were cultured for 72 h in the absence (control) or presence of hPGH 
(20ng/ml), the Jak inhibitor AG490 (10µM), or hPGH (20ng/ml) plus AG490 (10µM). 
AG490 inhibited the effect of hPGH on the invasion index. Values are the mean  ± SEM of 
duplicate determinations for at least four independent cultures from different placentas. *, P  
< 0.05; **, P   < 0.001. 
 
Figure 4. Comparative expression of PAPP-A in human cultured VCT and EVCT and 
regulation by PPAR. 
Upper panel: Supernatants from 24, 48 and 72 h cultured VCT and EVCT were collected and 
PAPP-A quantified. Protein secretions were expressed as UI/L and normalized to DNA 
content for comparison between VCT and EVCT. Values represent the mean ± SEM of three 
independent cultures obtained from three different placentas. EVCT vs VCT: *P < 0.05; ** P 
< 0.01; *** P < 0.001 
Lower panel: PAPP-A secreted protein were measured in 48 h-cultured human EVCT or VCT 
treated or not with 1 M of the PPAR agonist rosiglitazone. Values were expressed relative 
to untreated cells and represent the mean ± SEM. For protein determination, six independent 
cultures from six different placentas were run in duplicate. Treated vs control: * P< 0.05 
 
Figure 5. Effects of oxidized LDLs and their ligands on EVCT invasion in vitro  
Upper panel: Extravillous cytotrophoblast were cultured in Matrigel-coated Transwells, 
incubated with increasing concentrations of native or copper-oxidised LDL for 48 h and 
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trophoblastic cell invasion quantified as previously described. Results represent the mean ± 
SEM of three independent cultures obtained from individual placentas run in triplicate. * P < 
0.05, treated vs. controls 
Middle panel: Schematic representation of a low-density lipoprotein and their components 
that provide potential ligands for PPAR and/or LXR after oxidation. 
Bottom panel:  Effects of natural ligands (plain) and synthetic agonists (hatched) of PPAR 
(brown) and LXR (yellow) on trophoblast invasion in vitro. Cells were incubated for 48 h 
with 9-HODE (3µM), 13-HODE (3µM), 15-HETE (3 µM), 15d-PGJ2 (10 µM), Rosiglitazone 
(1 µM), 7-ketocholesterol (7-ketoCH; 1µg.L
-1
) and the LXR agonist T0901317 (5 µM) and 
invasion assays were performed as described. Values represent the mean ± SEM of three 
independent cultures obtained from individual placentas and run in triplicate. * P < 0.05, 
treated vs. controls. 
 
Figure 6. Colocalisation in EVCT in situ of oxidized LDLs, LOX-1, PPAR and LXRß.  
Immunohistochemistry was performed on first trimester human placental sections. First 
trimester placental samples from legal first trimester abortion were obtained after informed 
consent of the patient. Placental sections were fixed in 4% formalin and then embedded in 
paraffin. Cytokeratin 7 (CK07) staining is specific of trophoblasts from extravillous (EVCT) 
or villous (VCT and ST) origin. OxLDL, the scavenger receptor LOX-1 involved in OxLDL 
uptake, PPAR and LXRß nuclear receptors were colocalized in EVCT. No staining is 
observed in control sections incubated with non-immune IgG. SC: stromal core.  
 
Figure 7. Schematic illustration of the hypothetical mechanisms involved in oxidized 
LDL-mediated inhibition of human trophoblast invasion.  
1) LOX-1-mediated uptake of oxidized LDLs present at the maternofetal interface; 2) release 
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of potential ligands for PPAR and LXR nuclear receptors (RN); 3) trans-repression of genes 
coding for factors involved in trophoblastic invasion such as hPGH or PAPP-A, a protease 
that cleaves IGF-BP4; 4) inhibition of hPGH synthesis and secretion and decrease in IGF-II 
availability; 5) two soluble factors that promote trophoblastic invasion in an 
autocrine/paracrine fashion. 
 
 
 
 
